MiPT
| MiPT | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||
| Common names | MiPT | ||||||||||||||||||
| Substitutive name | N-Methyl-N-isopropyltryptamine | ||||||||||||||||||
| Systematic name | N-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine | ||||||||||||||||||
| Class Membership | |||||||||||||||||||
| Psychoactive class | Psychedelic | ||||||||||||||||||
| Chemical class | Tryptamine | ||||||||||||||||||
| Routes of Administration | |||||||||||||||||||
|
|||||||||||||||||||
| Interactions | |||||||||||||||||||
| Summary sheet: MiPT |
MiPT (also known as 4-hydroxy-dipropyltryptamine) is a hallucinogenic psychedelic drug of the tryptamine class.
Alexander Shulgin first synthesized MiPT and documented it in his book TiHKAL (Tryptamines I Have Known and Loved). It is the methyl analog of DiPT.[1]
Today it is either used recreationally or as an entheogenic compound and is typically acquired through the use of online research chemical vendors. It remains relatively uncommon even for a substituted tryptamine and has very little history of human usage.
Chemistry
 |
This chemistry section is incomplete. You can help by adding to it. |
Pharmacology
Like with most psychedelic tryptamines, MiPT is thought to act principally as a 5-HT2A partial agonist. The psychedelic effects are believed to come from MiPT's binding efficacy at the 5-HT2A receptors.
However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
Subjective effects
 |
This subjective effects section is a stub. As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it. |
The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.
Physical effects
- Spontaneous tactile sensations
- Bodily control enhancement
- Increased heart rate
- Nausea
- Pupil dilation
Cognitive effects
- Conceptual thinking
- Cognitive euphoria
- Delusions
- Emotion enhancement
- Immersion enhancement
- Increased music appreciation
- Memory suppression
- Novelty enhancement
- Personal bias suppression
- Thought acceleration
- Thought loops
- Time distortion
- Unity and interconnectedness
Visual effects
Enhancements
Suppressions
Distortions
- Drifting (melting, breathing, morphing and flowing)
- Colour shifting
- Depth perception distortions
- Perspective distortions
- Symmetrical texture repetition
- Tracers
- After images
- Brightness alteration
- Diffraction
Hallucinatory states
- Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots)
Auditory effects
Toxicity and harm potential
 Main articles: Research chemicals § Toxicity and harm potential & Responsible use § Hallucinogens
|
The toxicity and long-term health effects of recreational MiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because MiPT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried MiPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
It is strongly recommended that one use harm reduction practices when using this drug.
Tolerance and addiction potential
MiPT is not habit-forming and the desire to use it can actually decrease with regular consumption. Like with most psychedelics it is most often thought to be self-regulating.
Tolerance to the effects of MiPT are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). MiPT presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of MiPT all psychedelics will have a reduced effect.
Legal issues
Due to its relative obscurity, the possession and sale of MiPT is unscheduled in most countries.
- United Kingdom - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[2]
See also
External links
References
- ↑ https://www.erowid.org/library/books_online/tihkal/tihkal17.shtml Entry in TIHKAL
- ↑ Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted